Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

Completed

Open to: ALL

Age: 18.0 - 55.0

Medical Conditions

Angioedema
Angioedemas, Hereditary


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


This is an open-label, three part study to evaluate the effect of BCX7353 on drug transporters as well as the effect of an inhibitor of drug transport on BCX7353.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Feb 2017 Aug 2017

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : Day 11-18 for Cohort 1, Day 7-14 for Cohort 2, Day 1 for Cohort 3

Intervention Arm Group : Cohort 1;Cohort 2;Cohort 3;

Intervention Type : DRUG
Intervention Description : Day 1 of Cohort 1

Intervention Arm Group : Cohort 1;

Intervention Type : DRUG
Intervention Description : Day 19 of Cohort 1

Intervention Arm Group : Cohort 1;

Intervention Type : DRUG
Intervention Description : Day 1 of Cohort 2

Intervention Arm Group : Cohort 2;

Intervention Type : DRUG
Intervention Description : Day 15 of Cohort 1

Intervention Arm Group : Cohort 2;

Intervention Type : DRUG
Intervention Description : Day 14 of Cohort 3

Intervention Arm Group : Cohort 3;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Covance CRU
    Leeds
    LS2 9LH


The study is sponsored by BioCryst Pharmaceuticals




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT03136237
Last updated 24 October 2017

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.